Velicept scores $21 mln Series B
Malvern, Pennsylvania-based Velicept Therapeutics, a clinical development company focused on advancing best-in-class medicines, has raised $21 million in Series B funding. CAM Capital and Longitude Capital led the round.
2 December 2015•2 mins read
